[1]
Kwatra, S.G. et al. 2024. Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib. Acta Dermato-Venereologica. 104, (May 2024), adv18452. DOI:https://doi.org/10.2340/actadv.v104.18452.